Clinical Trial Update: Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets [Phase 1]

View source ↗

Summary

Phase 1 sensory evaluation study of dexlansoprazole delayed-release orally disintegrating tablets completed, with results posted in 2015 regarding its use for g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease, Erosive Esophagitis | Phase 1 | Status: COMPLETED | Results posted: 2015-03-06